• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

One in Five Pregnant Individuals Miss Proper Syphilis Screening, Study Finds

Bioengineer by Bioengineer
May 19, 2026
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a striking revelation published in the Canadian Medical Association Journal (CMAJ), a comprehensive population-based retrospective cohort study has shed light on critical gaps in prenatal syphilis screening across Ontario, Canada. The research uncovers that one in five pregnant individuals did not receive timely screening for syphilis, a sexually transmitted infection with potentially devastating consequences if transmitted from mother to child during pregnancy or delivery. This gap in screening is particularly alarming given the sharp rise in infectious syphilis cases and congenital syphilis rates in the region in recent years.

Syphilis, caused by the bacterium Treponema pallidum, poses a significant threat to fetal and neonatal health. When left untreated, maternal syphilis can result in severe pregnancy outcomes such as miscarriage, stillbirth, preterm birth, and congenital infection. The pathogenesis involves transplacental passage of the bacteria, leading to systemic infection in the fetus, which may manifest as developmental anomalies or mortality in the neonate. This underlines the importance of early and adequate screening and treatment during pregnancy.

Global obstetrics guidelines mandate universal syphilis screening during the initial prenatal visit or within the first trimester, a critical period where intervention via antibiotic therapy, principally penicillin, can dramatically reduce vertical transmission risk. However, the findings from this extensive analysis of over half a million pregnancies in Ontario reveal that despite these recommendations, a significant proportion of pregnant individuals fail to receive screening at the optimal time.

The study cohort included 551,706 pregnancies among 446,660 individuals from 2018 to 2023, representing the largest province in Canada with diverse populations. Remarkably, 8% of these pregnant individuals were not screened for syphilis at all, while only 79% received screening within the first trimester. Approximately 3% were screened late in the third trimester or even at delivery, when preventive interventions may be too late to prevent adverse outcomes. This late screening cohort likely represents populations facing substantial barriers to accessing timely prenatal care.

Delving deeper into sociodemographic and behavioral determinants, the research highlights disparities linked to inadequate prenatal care access. Factors such as socioeconomic status, geographic location, cultural and linguistic barriers, and possibly stigma surrounding sexually transmitted infections emerge as critical contributors to delayed or missed screening. These observations suggest that traditional prenatal care models, often reliant on scheduled visits within established healthcare frameworks, may fail to engage vulnerable populations effectively.

The authors emphasize that addressing this screening gap requires a multifaceted approach beyond the conventional healthcare pathways. Integrating opportunistic screening during other healthcare encounters, deploying community-based outreach programs, and implementing point-of-care testing within diverse settings are potential strategies to enhance early detection rates. Point-of-care testing, offering rapid results without the need for laboratory infrastructure, is particularly advantageous for underserved or remote populations.

Such proactive measures align with the broader public health objective of reducing congenital syphilis incidence, which has alarmingly increased from 0.3 to 14.5 cases per 100,000 live births over the past decade. This trend mirrors the rising infectious syphilis rates among reproductive-aged females, which escalated from 2.3 to 53.8 cases per 100,000 individuals. The interplay of these epidemiological trends underscores a growing public health challenge that demands urgent attention and innovative intervention strategies.

Furthermore, the research calls for prenatal care providers to adopt nonjudgmental, culturally sensitive approaches that build trust and encourage health-seeking behaviors among marginalized groups. Comprehensive care models that intertwine medical screening with psychosocial support are critical to overcoming the systemic barriers impeding timely syphilis screening.

The study also reflects broader implications for healthcare policy and resource allocation. Enhancing prenatal screening programs requires investment in training, equitable healthcare access, and community engagement to ensure that screening protocols translate into effective coverage. Policymakers are urged to consider these findings as a basis for revising prenatal care guidelines and operationalizing inclusive strategies that reach all segments of the population.

In conclusion, this extensive Ontario-based study illuminates a significant public health blind spot—the missed opportunities for early syphilis screening during pregnancy. Given the severe neonatal consequences of untreated maternal syphilis and the promising potential of early antibiotic intervention, closing this gap is imperative. Future research should focus on tailored interventions that address the intersectional challenges faced by vulnerable populations and evaluate the efficacy of alternative screening modalities.

Supporting this work is a Canadian Institutes of Health Research Catalyst Grant (STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C), underscoring the national priority placed on combating sexually transmitted infections through evidence-based approaches. The study represents a clarion call for healthcare practitioners, public health experts, and policymakers to collaborate toward eliminating congenital syphilis through comprehensive, accessible, and timely prenatal screening.

Subject of Research: People
Article Title: Uptake of prenatal syphilis screening and its determinants in Ontario, Canada: a population-based retrospective cohort study
News Publication Date: 19-May-2026
Web References: https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251757
References: DOI 10.1503/cmaj.251757
Keywords: Prenatal care, Obstetrics, Midwifery, Pregnancy complications, Sexually transmitted diseases, Syphilis, Preventive medicine

Tags: antibiotic treatment for maternal syphiliscongenital syphilis preventionearly syphilis detection prenatal careimpact of untreated syphilis on fetusmaternal syphilis risksprenatal care guidelines Ontarioprenatal syphilis screening gapsrising syphilis rates Canadasyphilis screening compliance in pregnancysyphilis screening in pregnancyTreponema pallidum infection pregnancyvertical transmission of syphilis

Share12Tweet8Share2ShareShareShare2

Related Posts

Flame retardant BDE-209 targets molecularly linked to ulcerative colitis

July 6, 2026

Kidney transplant outcomes in older adults studied by German researchers

July 6, 2026

Salmonella protein SopB curbs early inflammation to slow disease progression

July 6, 2026

Multi-metal cooperation drives lung cancer chemoresistance, reversed by MiADMSA

July 6, 2026

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Flame retardant BDE-209 targets molecularly linked to ulcerative colitis

Ultra-high frequency particle impacts mimic rockbursts to shatter hard rock

Kidney transplant outcomes in older adults studied by German researchers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.